Protocol #GSK3772847: A randomized, double-blind, parallel group, multicenter, stratified study evaluating the efficacy and safety of repeat doses of GSK3772847 compared with placebo in participants with moderately severe asthma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/29/18 → 8/28/20

Funding

  • Parexel International ( Award # ): $6,554.84